Rinaldo Poncio Mendes
Overview
Explore the profile of Rinaldo Poncio Mendes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
744
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Druzian A, de Oliveira Franca A, Higa-Junior M, Dorval M, Lima-Junior M, Pompilio M, et al.
Acta Trop
. 2024 Oct;
260:107441.
PMID: 39481509
Visceral leishmaniasis (VL) poses a serious health threat, particularly when untreated, necessitating accurate diagnosis. While the gold-standard method involves identifying amastigotes in bone marrow aspirate (BMA), this procedure is invasive...
2.
Negri A, Nunes M, Lima G, Venturini J, Oliveira S, Lazera M, et al.
J Fungi (Basel)
. 2024 Jul;
10(7).
PMID: 39057375
This study aimed to estimate the prevalence of cryptococcal antigenemia detected by lateral flow assay (LFA) in AIDS patients and its accuracy in the diagnosis of cryptococcosis. Conducted at a...
3.
Brito E, de Oliveira Franca A, Siqueira I, Felix V, Rezende A, Amorim B, et al.
J Fungi (Basel)
. 2024 May;
10(5).
PMID: 38786672
Blood count is crucial for assessing bone marrow's cell production and differentiation during infections, gaging disease severity, and monitoring therapeutic responses. The profile of blood count in chronic forms of...
4.
Fabris L, Oliveira N, Bortolomai B, Batista L, Sobral M, Ribeiro A, et al.
J Fungi (Basel)
. 2024 Mar;
10(3).
PMID: 38535174
The incidence of paracoccidioidomycosis (PCM) varies in Latin America, and it is influenced by environmental factors. This study evaluated the distribution of PCM acute/subacute form (AF) cases and their correlation...
5.
Pereira B, Cavalcante R, Pereira-Chioccola V, de Souza Carvalho Melhem M, de Carvalho L, Mendes R
Microorganisms
. 2024 Feb;
12(2).
PMID: 38399756
Introduction: This study standardized a semi-quantitative dot blotting assay (DB) and a quantitative real-time polymerase chain reaction (qPCR) to detect specific antibodies for and its DNA in PCM patients. Methodology:...
6.
Koehler A, Scroferneker M, de Souza N, de Moraes P, Pereira B, Cavalcante R, et al.
J Fungi (Basel)
. 2024 Feb;
10(2).
PMID: 38392819
Paracoccidioidomycosis (PCM) is a systemic mycosis that is diagnosed by visualizing the fungus in clinical samples or by other methods, like serological techniques. However, all PCM diagnostic methods have limitations....
7.
Brito E, Siqueira I, Venturini J, Felix V, Dos Santos A, Mendes R, et al.
PLoS One
. 2023 Jun;
18(6):e0282218.
PMID: 37347744
Paracoccidioidomycosis (PCM) is caused by Paracoccidioides spp.; during infection, some host mechanisms limit the availability of iron, thereby reducing its reproduction. However, Paracoccidioides spp. can evade the immune defense and,...
8.
Tomazini K, Pereira B, Sylvestre T, Cavalcante R, de Carvalho L, Mendes R
J Venom Anim Toxins Incl Trop Dis
. 2023 Jan;
29:e20220045.
PMID: 36660367
Background: Serological evaluation performed by double agar gel immunodiffusion test (DID) is used for diagnosis, evaluation of severity, management of paracoccidioidomycosis patients, and development of new clinical studies. For these...
9.
Ribeiro S, Nunes T, Cavalcante R, Paniago A, Pereira B, Mendes R
J Venom Anim Toxins Incl Trop Dis
. 2022 Dec;
28:e20220053.
PMID: 36465893
The lungs have great importance in patients with paracoccidioidomycosis since they are the portal of entry for the infecting fungi, the site of quiescent foci, and one of the most...
10.
Levorato-Vinche A, de Souza Carvalho Melhem M, Bonfietti L, De-la-Cruz-Chacon I, Boaro C, Fabro A, et al.
J Venom Anim Toxins Incl Trop Dis
. 2022 Sep;
28:e20220006.
PMID: 36118844
Background: Cryptoccocal meningitis continues to present high incidence among AIDS patients. The treatment of choice is the synergistic combination of flucytosine (5-FC) with amphotericin B deoxycholate (AmBd) or its lipid...